Tumor infiltrating lymphocyte (TIL) density was higher in DCIS lesions with TP53 mutations (p=0.0079) compared to wildtype lesions, but not in lesions with <i>PIK3CA</i> mutations (p=0.44). This evidence concerns the gene TP53 and ductal breast carcinoma in situ.